Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Current Taxes (2017 - 2025)

Icu Medical's Current Taxes history spans 10 years, with the latest figure at $10.4 million for Q4 2025.

  • For the quarter ending Q4 2025, Current Taxes fell 39.98% year-over-year to $10.4 million, compared with a TTM value of $10.4 million through Dec 2025, down 39.98%, and an annual FY2025 reading of $10.4 million, down 39.98% over the prior year.
  • Current Taxes for Q4 2025 was $10.4 million at Icu Medical, up from $5.0 million in the prior quarter.
  • The five-year high for Current Taxes was $20.0 million in Q2 2023, with the low at $159000.0 in Q2 2025.
  • Average Current Taxes over 5 years is $8.1 million, with a median of $5.9 million recorded in 2022.
  • Year-over-year, Current Taxes surged 1100.48% in 2022 and then plummeted 96.16% in 2025.
  • Tracing ICUI's Current Taxes over 5 years: stood at $1.5 million in 2021, then skyrocketed by 326.41% to $6.2 million in 2022, then increased by 24.42% to $7.7 million in 2023, then soared by 124.63% to $17.3 million in 2024, then crashed by 39.98% to $10.4 million in 2025.
  • Per Business Quant, the three most recent readings for ICUI's Current Taxes are $10.4 million (Q4 2025), $5.0 million (Q3 2025), and $159000.0 (Q2 2025).